Business Wire

Varför förtjänar det taiwanesiska skönhetsmärket O’right en gyllene biljett till den nordiska marknaden?

Dela

I takt med att coronaviruset sprider sig runt om i världen fortsätter det taiwanesiska gröna skönhetsmärket O’right att göra omfattande framsteg inom hållbarhet. I år skapade O’right rubriker genom att öppna sin butik i Isetan Shinjuku, ett av de större varuhusen i Japan. Nu har det innovativa märket nått Lyko, en svensk skönhets- och hårvårdskedja som snabbt har blivit den nordiska marknadens ledande aktör i branschen. Nyligen tilldelades den gröna innovatören Good Design Gold Award (Japans Good Design Award är en av världens fyra främsta utmärkelser inom design) för sin senaste innovation – världens grönaste tandkräm – för att erbjuda nya gröna lifestyle-lösningar världen över. O’right forsätter sitt åtagande att göra det bästa för människorna, samhället och jorden och uppmanar företag och människor att följa detta exempel. Det som började som ett litet och okänt namn i Taiwan har nu utvecklats till ett skönhetsmärke med noll koldioxidavtryck som tar skönhetsbranschen med stormsteg.

Detta pressmeddelande använder multimedia. Se den fullständiga versionen här: https://www.businesswire.com/news/home/20201118005487/sv/

Lyko joins forces with O’right, opening the door for the Taiwanese brand to make its green values and products seen in the Nordic region. (Photo: Business Wire)

Lyko joins forces with O’right, opening the door for the Taiwanese brand to make its green values and products seen in the Nordic region. (Photo: Business Wire)

Ett visionärt varumärke som är här för att stanna

O’right och den svenska skönhetsåterförsäljaren Lyko möttes på Cosmoprof Bologna. Lyko grundades i världens mest hållbara land. De samarbetar med varumärken och lagerför produkter som överensstämmer med deras egna värderingar och uppfyller deras höga krav. O’right har visat vägen mot hållbarhet i flera år, från sin innovativa 8 Free-standard för att skapa giftfria, rena och flerfaldigt prisbelönta gröna produkter till att nyligen motta etiketten ”USDA Certified Biobased Product”. I år siktar företaget på att uppnå noll koldioxidavtryck (koldioxidneutralitet) för 77 av sina produkter. O’right’s åtagande för hållbarhet återspeglas inte bara i dess värderingar, utan även från produktformler till förpackningar. Det banbrytande företaget uppvisar en positiv social och miljömässig inverkan samt kraftfulla visionära budskap som rättfärdigar dess värde och inspirerade den svenska kedjan att investera helhjärtat i. Man kan lugnt säga att kosmetikabranschen ser på med spänning medan partnerskapet mellan två företag med samma värderingar från öst och väst blommar ut i något fantastiskt.

Grönt utan gränser

Lyko driver Sveriges största e-handelssajt med 4 miljoner besökare i månaden i genomsnitt, tillsammans med 37 fysiska butiker i Sverige och Norge. Lyko samarbetar med O’right och öppnar portarna för det taiwanesiska märkets intåg med sina gröna värderingar och produkter på den nordiska marknaden. O’rights gröna produkter har till och med hamnat på e-handelsplattformens försäljartopplista. Som ett märke med noll koldioxidavtryck anser O’right att nyckeln till större inflytande i alla delar av världen är att inspirera till gröna levnadssätt och konsumtionsvanor. När det gäller hållbarhet spelar avstånd och nationsgränser ingen roll.

Har O’right, ett litet taiwanesiskt företag från det lilla landet Taiwan, vad som krävs för att erövra den nordiska marknadens skönhetssektor? O’right är fast beslutet om att visa upp sina gröna värderingar och imponera på kunderna med sina holistiska, gröna livsstilslösningar och innovativa trender.

Detta meddelandes ursprungliga källspråkstext är den officiella versionen. Översättningar tillhandahålls endast som ett stöd och skall jämföras med källspråkstexten, vilken är den enda versionen av texten som har rättslig verkan.

Contact information

Lorella Chan
Public Relations Specialist
Telefon: +886 (3) - 4116789
E-post: Lorella_Chan@oright.com.tw

Om

Business Wire
Business Wire



Följ Business Wire

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från Business Wire

Colicity Inc. Announces Closing of $345 Million Initial Public Offering26.2.2021 23:00:00 CETPress release

Colicity Inc. (the “Company”) announced the closing today of its initial public offering of 34,500,000 units, including the underwriters’ exercise of their full over-allotment option for 4,500,000 units, at a price of $10.00 per unit. The units are listed on the NASDAQ Stock Market (NASDAQ) and began trading under the ticker symbol “COLIU” on February 24, 2021. Each unit consists of one Class A share and one-fifth of one redeemable warrant, with each whole warrant exercisable to purchase one Class A share at a price of $11.50 per share. Only whole warrants will be exercisable. Once the securities comprising the units begin separate trading, the Class A shares and warrants are expected to be listed on the NASDAQ under the symbols “COLI” and “COLIW,” respectively. Colicity Inc. is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company int

C3 AI and Baker Hughes to Provide Enterprise AI Solutions to Accelerate PETRONAS Digital Transformation Program26.2.2021 15:00:00 CETPress release

C3 AI (NYSE: AI) and Baker Hughes today announced an artificial intelligence (AI) collaboration with PETRONAS, a global energy and solutions company from Malaysia, to apply BakerHughesC3.ai (BHC3) technology across PETRONAS’s strategic digital transformation programs. As the custodian of Malaysia's national oil and gas resources, PETRONAS runs an extensive digital transformation program across energy operations to extract value from data. The adoption of AI as part of its overall program for improved oil and gas productivity, asset integrity, and safety supports PETRONAS’s commitment to provide clean, efficient energy solutions by harnessing the power of technology. PETRONAS will work with energy technology, data science, and AI experts at Baker Hughes and C3 AI to collaborate on projects focused on improved reliability of energy assets in critical operations. Utilizing Microsoft Azure, PETRONAS will deploy the BHC3™ Reliability application to further improve maintenance programs for g

Avania in Position for Next Stage of Growth26.2.2021 14:00:00 CETPress release

Avania, a leading global full-service contract research organization (CRO) focused on medical technology (MedTech) development, today announced that it has successfully refinanced its existing banking facilities with Crescent Capital Group. “This new banking facility allows us to accelerate our next phase of organic and acquisitive growth over the next few years,” said Edo van Houten, CFO of Avania. “This transaction is also a reflection of the progress we have made in our brand strategy and position in the market, and it demonstrates the confidence of the financial community in our operational and strategic plan.” Avania has navigated confidently through the COVID-19 pandemic, posting a strong year of growth in 2020 despite the pandemic. The company will continue its growth trajectory as a global MedTech-focused CRO, supporting products from concept through post-market support. MedTech is all Avania does, navigating innovative medical technologies to market effectively and efficiently

Ipsen Receives Positive CHMP Opinion Recommending Cabometyx ® in Combination With Opdivo ® as First-line Treatment for Patients Living With Advanced Renal Cell Carcinoma26.2.2021 12:37:00 CETPress release

Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval for Cabometyx® (cabozantinib) in combination with Bristol Myers Squibb’s Opdivo® (nivolumab) for the first-line treatment of advanced renal cell carcinoma (aRCC). The European Commission, which has the authority to approve medicines for the European Union (E.U.), will now review the CHMP recommendation and a final decision on the application in the E.U. is expected in the coming months. “Advanced renal cell carcinoma is a disease that significantly impacts the lives of people around the world. We’re proud to be able to share that the CHMP has confirmed a positive recommendation for Cabometyx® in combination with Opdivo®, bringing this impactful new treatment option one step closer for patients,” said Howard Mayer, Executive Vice President and Head of Research and Development, Ipsen. “At Ipsen, w

Hiro Capital Leads $15 Million of Games VC Investment Into Snowprint Studios, Double Loop Games and Happy Volcano Games26.2.2021 09:55:00 CETPress release

Three international video game studios are the latest investments for Hiro Capital, the entrepreneur-led Venture Capital fund focused on backing innovators in Video Games, the Metaverse, Esports and Digital Fitness. The three mobile and cross-platform studios – Snowprint in Stockholm/Berlin, Double Loop Games in San Francisco and Happy Volcano in Belgium – will use Hiro’s investment to expand their development pipelines and accelerate global growth. They join UK and US Games studios Flavourworks, Polyarc and Lightfox in the Hiro Capital portfolio, alongside pioneers in the gamification of Games Streaming and Digital Fitness LIV.tv, Edgegap,FitXR and Nurvv. Ian Livingstone, co-founding partner at Hiro Capital, said, "We are excited to begin 2021 by announcing Hiro's investment in three amazing games studios, Snowprint, Double Loop and Happy Volcano. Each studio has demonstrated innovation and expertise in developing fun to play games which resonate with today’s audiences. I’m especially

Inspur Information Releases 2020 Global Computing Index Report26.2.2021 09:07:00 CETPress release

Inspur Information, a leading IT infrastructure solutions provider, has sponsored an International Data Corporation (IDC) white paper on the 2020 Global Computing Index (henceforth referred to as The Report). As the world’s first index report on computing, The Report unveils the relationship between computing power and economic development and serves as a reference for the outlook of the global digital economy. Global digital transformation has entered a phase marked by exponential growth in innovation, with the size of the digital economy projected to continue on an upward trend. As a key factor that underlies digital technology development, computing is now defining the productivity of the digital economy era. According to The Report, economic growth directly correlates with the development of computing—one point of growth in the computing index translates to a 3.3‰ rise in the size of the digital economy and a 1.8‰ growth in GDP. Specifically, AI computing market share is projected

Incyte Announces the Validation by the European Medicines Agency of its Marketing Authorization Application for Retifanlimab as a Treatment for Patients with Squamous Cell Anal Carcinoma (SCAC)26.2.2021 09:00:00 CETPress release

Incyte (Nasdaq:INCY) today announced the validation of the Company’s Marketing Authorization Application (MAA) for retifanlimab, an intravenous PD-1 inhibitor, as a potential treatment for adult patients with locally advanced or metastatic squamous cell anal carcinoma (SCAC) who have progressed on, or who are intolerant of, platinum-based chemotherapy. The European Medicines Agency’s (EMA) validation of the MAA confirms that the submission is sufficiently complete to begin the formal review process. “While the incidence of SCAC is increasing in Europe, treatment options for advanced disease are limited in their effectiveness, and there are no approved options once patients have progressed on standard therapy,” said Lance Leopold, M.D., Group Vice President, Immuno-Oncology Clinical Development, Incyte. “The EMA validation of the MAA for retifanlimab – which follows the recent U.S. Food & Drug Administration acceptance of our Biologics License Application for Priority Review – brings us

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum